Title:A Phase 3, Double Blind, Randomized, Placebo-Controlled Study Of The Safety And Effectiveness of AA4500 Administered Twice Per Treatment Cycle For Up To Four Cycles (2x4) in Men With Peyronie's Disease.
Purpose of Study
The purpose of this study is to assess the effectiveness of AA4500 determined by change in the Peyronie's disease (PD) and percent change in penile curvature at Day 364.
For further information click here.
Clinical Research Coordinators:
Lisa Bennett, RN or Erica Sica,RN (336) 274-1114 ext. 5322